Miwa Morita1, Daniel Joyce2, Charles Miller2, John J Fung2, Lina Lu1,2, Shiguang Qian1,2. 1. Department of Immunology, Lerner Research InstituteCleveland Clinic, Cleveland, OH. 2. Department of General Surgery, Transplant Center, Digestive Disease Institute, Cleveland Clinic, Cleveland, OH.
Abstract
UNLABELLED: Liver tolerance was initially recognized by the spontaneous acceptance of liver allografts in many species. The underlying mechanisms are not completely understood. However, liver transplant (LT) tolerance absolutely requires interferon (IFN)-γ, a rejection-associated inflammatory cytokine. In this study, we investigated the rejection of liver allografts deficient in the IFN-γ receptor and reveal that the liver graft is equipped with machineries capable of counterattacking the host immune response through a mesenchyme-mediated immune control (MMIC) mechanism. MMIC is triggered by T effector (Tef) cell-derived IFN-γ that drives expression of B7-H1 on graft mesenchymal cells leading to Tef cell apoptosis. We describe the negative feedback loop between graft mesenchymal and Tef cells that ultimately results in LT tolerance. Comparable elevations of T-regulatory cells and myeloid-derived suppressor cells were observed in both rejection and tolerance groups and were not dependent on IFN-γ stimulation, suggesting a critical role of Tef cell elimination in tolerance induction. We identify potent MMIC activity in hepatic stellate cells and liver sinusoidal endothelial cells. MMIC is unlikely exclusive to the liver, given that spontaneous acceptance of kidney allografts has been reported, although less commonly, probably reflecting variance in MMIC activity. CONCLUSION: MMIC may represent an important homeostatic mechanism that supports peripheral tolerance and could be a target for the prevention and treatment of transplant rejection. This study highlights that the graft is an active participant in the equipoise between tolerance and rejection and warrants more attention in the search for tolerance biomarkers.
UNLABELLED: Liver tolerance was initially recognized by the spontaneous acceptance of liver allografts in many species. The underlying mechanisms are not completely understood. However, liver transplant (LT) tolerance absolutely requires interferon (IFN)-γ, a rejection-associated inflammatory cytokine. In this study, we investigated the rejection of liver allografts deficient in the IFN-γ receptor and reveal that the liver graft is equipped with machineries capable of counterattacking the host immune response through a mesenchyme-mediated immune control (MMIC) mechanism. MMIC is triggered by T effector (Tef) cell-derived IFN-γ that drives expression of B7-H1 on graft mesenchymal cells leading to Tef cell apoptosis. We describe the negative feedback loop between graft mesenchymal and Tef cells that ultimately results in LT tolerance. Comparable elevations of T-regulatory cells and myeloid-derived suppressor cells were observed in both rejection and tolerance groups and were not dependent on IFN-γ stimulation, suggesting a critical role of Tef cell elimination in tolerance induction. We identify potent MMIC activity in hepatic stellate cells and liver sinusoidal endothelial cells. MMIC is unlikely exclusive to the liver, given that spontaneous acceptance of kidney allografts has been reported, although less commonly, probably reflecting variance in MMIC activity. CONCLUSION: MMIC may represent an important homeostatic mechanism that supports peripheral tolerance and could be a target for the prevention and treatment of transplant rejection. This study highlights that the graft is an active participant in the equipoise between tolerance and rejection and warrants more attention in the search for tolerance biomarkers.
Authors: Pervinder Sagoo; Esperanza Perucha; Birgit Sawitzki; Stefan Tomiuk; David A Stephens; Patrick Miqueu; Stephanie Chapman; Ligia Craciun; Ruhena Sergeant; Sophie Brouard; Flavia Rovis; Elvira Jimenez; Amany Ballow; Magali Giral; Irene Rebollo-Mesa; Alain Le Moine; Cecile Braudeau; Rachel Hilton; Bernhard Gerstmayer; Katarzyna Bourcier; Adnan Sharif; Magdalena Krajewska; Graham M Lord; Ian Roberts; Michel Goldman; Kathryn J Wood; Kenneth Newell; Vicki Seyfert-Margolis; Anthony N Warrens; Uwe Janssen; Hans-Dieter Volk; Jean-Paul Soulillou; Maria P Hernandez-Fuentes; Robert I Lechler Journal: J Clin Invest Date: 2010-05-24 Impact factor: 14.808
Authors: Anna Schurich; Martina Berg; Dirk Stabenow; Jan Böttcher; Michaela Kern; Hans-Jörg Schild; Christian Kurts; Verena Schuette; Sven Burgdorf; Linda Diehl; Andreas Limmer; Percy A Knolle Journal: J Immunol Date: 2010-03-08 Impact factor: 5.422
Authors: M Morita; M Fujino; G Jiang; Y Kitazawa; L Xie; M Azuma; H Yagita; S Nagao; A Sugioka; Y Kurosawa; S Takahara; J Fung; S Qian; L Lu; X-K Li Journal: Am J Transplant Date: 2009-11-04 Impact factor: 8.086
Authors: John D Scandling; Stephan Busque; Judith A Shizuru; Edgar G Engleman; Samuel Strober Journal: N Engl J Med Date: 2011-10-06 Impact factor: 91.245
Authors: Tina S Mele; Norman M Kneteman; Lin-Fu Zhu; Vido Ramassar; Joan Urmson; Brendan Halloran; Thomas A Churchill; Lawrence Jewell; Kevin Kane; Philip F Halloran Journal: Am J Transplant Date: 2003-08 Impact factor: 8.086
Authors: M Figliuzzi; R Cornolti; N Perico; C Rota; M Morigi; G Remuzzi; A Remuzzi; A Benigni Journal: Transplant Proc Date: 2009-06 Impact factor: 1.066
Authors: Yoshihiro Ono; Angelica Perez-Gutierrez; Toshimasa Nakao; Helong Dai; Geoffrey Camirand; Osamu Yoshida; Shinichiro Yokota; Donna Beer Stolz; Mark A Ross; Adrian E Morelli; David A Geller; Angus W Thomson Journal: Hepatology Date: 2018-02-18 Impact factor: 17.425